Sacco Christine 4
4 · Prestige Consumer Healthcare Inc. · Filed Nov 14, 2024
Insider Transaction Report
Form 4
Sacco Christine
CFO & COO
Transactions
- Exercise/Conversion
Common Stock, par value $0.01 per share
2024-11-12$30.56/sh+24,686$754,404→ 54,809 total - Sale
Common Stock, par value $0.01 per share
2024-11-12$82.01/sh−24,686$2,024,499→ 30,123 total - Exercise/Conversion
Employee Stock Options (rights to buy)
2024-11-12−24,686→ 0 totalExercise: $30.56Exp: 2029-05-06→ Common Stock (24,686 underlying)
Footnotes (2)
- [F1]Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $81.87 to $82.30.
- [F2]The options vested in three installments of 8,228 shares on May 6, 2020 and 8,229 shares each on May 6, 2021 and May 6, 2022.